Our Novel Vectors Deliver on Gene Therapy’s Promise.

BioMarin is the world leader in delivering therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases.

With accelerated review underway in the United States and Europe for our Gene Therapy for Hemophilia A drug, a second gene therapy program entering the clinic for PKU patients, and a third program in late research for Hereditary Angioedema, BioMarin continues to pioneer innovative approaches to treating rare diseases.

Our commitment to gene therapy is further emphasized by having developed the first and largest gene therapy manufacturing facility in the world.

The scientific possibilities and the hope we offer to patients with rare diseases is enormous.

Rare Opportunities, Personal Impact.



Research Associate II / Sr Research Associate I, Capsid Engineering & Development, Gene Therapy 

What Makes Us Special

Hope. It's where BioMarin's story begins. It's what we work to deliver every day. And it’s what makes being here truly special. Good people doing work that does good. Powerful therapies empowering people’s lives. Rare opportunities sprung from treating rare diseases. These things shape the work experience and provide a powerful connection between who you are, the work you do, and the life-changing hope it delivers. As a biopharmaceutical company, our success stems from our unwavering focus on science and the hope our therapies can bring to patients and their families.









We'll Help You Get Here

BioMarin offers a comprehensive relocation program including:

Private neighborhood exploration guide with a local realtor.
Corporate housing in a furnished local apartment.
Assistance with home purchase/home sale.


***subject to program guidelines and qualifications***

Golden Gate Bridge


 . . .